These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 613563

  • 1. [What role does the renin-angiotensin system have in the pathogenesis of hypertension?].
    Gross F, Dietz R, Lüth JB, Mann JF.
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():177-87. PubMed ID: 613563
    [No Abstract] [Full Text] [Related]

  • 2. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK, Williams GH.
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE.
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [Abstract] [Full Text] [Related]

  • 8. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK, Williams GH.
    Adv Intern Med; 1980 May; 25():327-61. PubMed ID: 6153859
    [No Abstract] [Full Text] [Related]

  • 9. The Distinguished Lecture. Is hypertension essential?
    Liddle GW.
    Trans Assoc Am Physicians; 1975 May; 88():55-69. PubMed ID: 131398
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathophysiology of angiotensin-salt hypertension.
    Muirhead EE, Leach BE, Davis JO, Armstrong FB, Pitcock JA, Brosius WL.
    J Lab Clin Med; 1975 May; 85(5):734-45. PubMed ID: 1123557
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
    Williams GH, Hollenberg NK, Brown C, Mersey JH.
    J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
    [Abstract] [Full Text] [Related]

  • 18. A new look at the hypertension problem: the role of the renin system for analysis and treatment.
    Laragh JH.
    Compr Ther; 1985 Oct; 11(10):6-17. PubMed ID: 3902342
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [SAR1, ALA8]-Angiotensin II (saralasin): a symposium. Introduction.
    Vaughan ED, Peach MJ.
    Kidney Int Suppl; 1979 Mar; (9):S1-2. PubMed ID: 289858
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.